Corebridge Financial (CRBG)
NYSEFinancialsAsset ManagementSnapshot 2026-09-09
$33.82+0.21%
Close 2026-09-09 · 1-day change
NYSEFinancialsAsset ManagementSnapshot 2026-09-09
Warn: Management is running behind on a stated commitment.
Corebridge is growing revenue about 10% a year. It returned $1.4 billion to shareholders in 2026-Q1. The merger with Equitable will improve scale and cash flow. Profit per share should reach $4.42 in 2026.
Corebridge is still loss-making and management is volatile. Earnings estimates have fallen recently. The merger could face delays or integration problems. Profit growth might stall below $4.42 per share in 2026.
The price is about 3% below our fair value near $32. Analysts expect about 10% revenue growth. Our view is aligned with consensus but cautious on execution risks.
Breaks if: Capital returned falls below $1 billion in 2026-Q1
Breaks if: EPS falls below $4.00 in FY26
Breaks if: Merger is delayed beyond FY26 or cancelled
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a turnaround situation with a focus on stabilizing operations and improving financial performance. The current thesis state is cautious, as the company has shown weak recent results and volatility in management execution.
The market appears to have priced in a low level of fragility, suggesting that investors are not overly concerned about immediate risks. However, the valuation is considered cheap compared to peers, indicating that expectations may be lower than for similar companies.
Fundamentals are likely to remain under pressure in the near term, given the company's loss-making status and weak recent performance. Management's focus on closing the merger with Equitable and returning capital to shareholders may provide some stability, but execution risks remain.
The long-term thesis hinges on the successful integration of the Equitable merger and the performance of sector bellwethers like BLK, BX, and KKR. If these companies continue to perform well, it could provide a favorable backdrop for CRBG.
The most important moves since the prior daily snapshot.
Signal changed from 'mixed' to 'mild_favorable'.
Yes, our read has strengthened. The latest earnings beat supports this improved outlook. There are no new threats identified that could weaken the thesis.
as of 2026-09-09
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Complete the all-stock merger with Equitable Holdings to create a combined company with enhanced scale, diversification, and cash generation.
Stated as a priority in 3 disclosures including 2026-Q1 and 2026-Q2 press releases and a May 2026 leadership announcement. The merger has reached shareholder approval and regulatory filings remain on track, with expected close by year-end 2026. Management is focused on execution and integration, indicating active delivery on this strategic priority.
“We have reached a pivotal milestone with shareholder approval and are now focused on the roadmap to final execution.”
“We are making excellent progress toward closing our transformative merger with Equitable, with regulatory filings on track.”
Breaks if: YoY revenue growth falls below 7% next year
Complete the all-stock merger with Equitable Holdings to create a combined company with enhanced scale, diversification, and cash generation.
Stated as a priority in 3 disclosures including 2026-Q1 and 2026-Q2 press releases and a May 2026 leadership announcement. The merger has reached shareholder approval and regulatory filings remain on track, with expected close by year-end 2026. Management is focused on execution and integration, indicating active delivery on this strategic priority.
“We have reached a pivotal milestone with shareholder approval and are now focused on the roadmap to final execution.”
“We are making excellent progress toward closing our transformative merger with Equitable, with regulatory filings on track.”
Over the next 1 to 3 years, CRBG's performance will depend on management's execution and sector dynamics. Not investment advice.